Literature DB >> 16633300

Gastroesophageal reflux disease in primary care. Prevalence, epidemiology and Quality of Life of patients.

Stanislas Bruley Des Varannes1, Lizzie Marek, Benoist Humeau, Marc Lecasble, Raymond Colin.   

Abstract

AIM: To determine the prevalence of typical symptoms of gastroesophageal reflux disease in a large group of patients consulting their general practitioners (GP) for diverse reasons, as well as the quality-of-life (QoL) of patients with such symptoms. PATIENTS AND METHODS: During the same day, participating GPs (N=3 200) systematically asked all of their patients about the presence of heartburn and regurgitation. For all patients who responded positively, the GPs filled in a questionnaire and the patient a specific QoL questionnaire.
RESULTS: Among 40 982 patients attending GP consultations, 4 124 (10.1%) had one or both symptoms. Prevalence was higher in men (11.1%) than in women (9.3%, P<0.001), and increased with age up to 50-59 yrs then slowly declined. Symptoms were present on a weekly basis in 72.8% of patients. Smoking, frequent or nocturnal occurrence of symptoms, regurgitation, and esophagitis were significantly linked up with a higher occurrence of extra-digestive symptoms (cough, ENT symptoms, chest pain). QoL declined with increasing frequency of symptoms, which especially affected food intake, psychology, well-being and daily life.
CONCLUSION: In France, typical symptoms of gastroesophageal reflux disease are observed in 10% of the adult population, and markedly alter their QoL.

Entities:  

Mesh:

Year:  2006        PMID: 16633300     DOI: 10.1016/s0399-8320(06)73189-x

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  9 in total

1.  Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitution.

Authors:  Stéphane Mouly; Agnès Charlemagne; Philippe Lejeunne; Francis Fagnani
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

Review 2.  Enhanced endoscopic imaging and gastroesophageal reflux disease.

Authors:  Rupa Banerjee; D Nageshwar Reddy
Journal:  Indian J Gastroenterol       Date:  2011-10-19

Review 3.  Cost-effectiveness of proton pump inhibitors versus laparoscopic Nissen fundoplication for patients with gastroesophageal reflux disease: a systematic review of the literature.

Authors:  Anthony S Thijssen; Ivo A M J Broeders; G Ardine de Wit; Werner A Draaisma
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

4.  Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease.

Authors:  Roberto Penagini; Rami Sweis; Aurelio Mauro; Gerson Domingues; Andres Vales; Daniel Sifrim
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

5.  The epidemiology of gastroesophageal reflux disease: a survey on the prevalence and the associated factors in a random sample of the general population in the Northern part of Iran.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Seyed Mehrbod Atshani; Sepideh Chagharvand; Fatemeh Souti
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

Review 6.  Sex and Gender Differences in Gastroesophageal Reflux Disease.

Authors:  Young Sun Kim; Nayoung Kim; Gwang Ha Kim
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

7.  Factors associated with dental erosions in gastroesophageal reflux disease: a cross-sectional study in patients with heartburn.

Authors:  Andrei Picos; Jean-Francois Lasserre; Andrea M Chisnoiu; Antonela M Berar; Emmanuel d'Incau; Alina M Picos; Alexandra Chira; Stanislas Bruley des Varannes; Dan L Dumitrascu
Journal:  Med Pharm Rep       Date:  2020-01-31

8.  Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France.

Authors:  Stanislas Bruley des Varannes; Helena Granstedt Löfman; Maria Karlsson; Peter Wahlqvist; Magnus Ruth; Mary Lou Furstnau; Nicolas Despiégel; Nils-Olov Stålhammar
Journal:  BMC Gastroenterol       Date:  2013-02-28       Impact factor: 3.067

9.  Chest pain in primary care: is the localization of pain diagnostically helpful in the critical evaluation of patients?--A cross sectional study.

Authors:  Stefan Bösner; Katharina Bönisch; Jörg Haasenritter; Patrice Schlegel; Eyke Hüllermeier; Norbert Donner-Banzhoff
Journal:  BMC Fam Pract       Date:  2013-10-18       Impact factor: 2.497

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.